During the past decade, AZ Turnhout - Campus Sint Elisabeth conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Turnhout - Campus Sint Elisabeth" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Abbott" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Turnhout - Campus Sint Elisabeth" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Arbeitsgemeinschaft fur Internistische Onkologie" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "AZ Turnhout - Campus Sint Elisabeth" are "Breast Cancer" (4 trials), "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Colorectal Cancer Metastatic" (2 trials) and "Pulmonary Disease, Chronic Obstructive" (2 trials). Many other conditions were trialed in "AZ Turnhout - Campus Sint Elisabeth" in a lesser frequency.

Most popular intervention types in "AZ Turnhout - Campus Sint Elisabeth" are "Drug" (21 trials), "Other" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials), "Bevacizumab" (2 trials), "Degarelix" (2 trials), "Paclitaxel" (2 trials) and "celecoxib" (2 trials). Other intervention names were less common.

The vast majority of trials in "AZ Turnhout - Campus Sint Elisabeth" are 16 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Turnhout - Campus Sint Elisabeth". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in AZ Turnhout - Campus Sint Elisabeth, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Turnhout - Campus Sint Elisabeth, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".